Asha Pillai, MD

Dr Beitinjaneh is a nationally recognized clinical research investigator with over a decade of experience in managing aggressive hematologic malignancies, particularly through cellular therapy and stem cell transplantation. He has published more than 100 peer-reviewed manuscripts and has led numerous novel interventional clinical trials, funded by both industry and federal agencies. Dr Beitinjaneh currently leads the Transplant, Cellular & Viral Therapy Site Disease Group at the NCI-designated Sylvester Cancer Center at the University of Miami (UM) and serves as the BMT CTN Network institutional PI. In addition to his research, Dr Beitinjaneh plays an active role on national critical committees such as ASTCT, CIBMTR, EBMT, and CTN.